Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
Distribution of COVID vaccines just got more complicated
Pfizer's and Modera's mRNA-based vaccines require low temperature storage which many distribution locations are not equipped. The logistic of shipping, storing and distributing to patients are the key hurdles to deliver medicines. This is not new but doable given the breath of science community in the developed countries. The more urgent concern are the poor countries who cannot afford billions to equip themselves in order to distribute the vaccines. Alternatively J&J, AstaZeneca and other vaccines that do not need the extreme low temperatures would be more suitable.
